What was Crown Baus Capital’s price range in the past 12 months?
Crown Baus Capital lowest stock price was $0.00 and its highest was $0.47 in the past 12 months.
What is Crown Baus Capital’s market cap?
Crown Baus Capital’s market cap is $161.
When is Crown Baus Capital’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Crown Baus Capital overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Crown Baus Capital pay dividends?
Crown Baus Capital does not currently pay dividends.
What is Crown Baus Capital’s EPS estimate?
Crown Baus Capital’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Crown Baus Capital have?
Crown Baus Capital has 161,050,000 shares outstanding.
Which hedge fund is a major shareholder of Crown Baus Capital?
Currently, no hedge funds are holding shares in CBCA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Crown Baus Capital
Crown Baus Capital Corp. is an acquisition-based conglomerate. It engages in vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups. It operates through the following divisions: Drug Development, High-Tech Incubation, Entertainment and Media, Financial Services, and Education. The company was founded by Raymond C. Dabney on August 8, 2011 and is headquartered in Surrey, Canada.